Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “B-Cell Non-Hodgkin's Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00004031
What this trial is testing

SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
SWOG Cancer Research Network 397
Early research (Phase 1)UnknownNCT03383952
What this trial is testing

A Clinical Study of CD19 Targeted CAR-T for Patients With CD19+ Lymphoma and Leukemia

Who this might be right for
B Cell LeukemiaB Cell Lymphoma
Immune Cell, Inc. 20
Early research (Phase 1)Not Yet RecruitingNCT07616089
What this trial is testing

Phase I Study of FXS0683 in the Treatment of Blood Tumors

Who this might be right for
B-Cell LymphomaAcute Myeloid LeukemiaMyelodysplastic Syndromes+1 more
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 228
Testing effectiveness (Phase 2)Study completedNCT01045889
What this trial is testing

High Dose Therapy and Peripheral Blood Stem Cell Transplantation in HIV Related Non Hodgkin Lymphoma (NHL) at High Risk

Who this might be right for
HIV-related LymphomaHIV Infections
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 27
Testing effectiveness (Phase 2)Ended earlyNCT00126243
What this trial is testing

Efficacy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With HIV Associated Non-Hodgkin's Lymphoma

Who this might be right for
AIDS Related Lymphoma
French National Agency for Research on AIDS and Viral Hepatitis 60
Testing effectiveness (Phase 2)Ended earlyNCT04161118
What this trial is testing

TisaGenlecleucel in Elderly Patients With First-Relapsed or Primary Refractory Aggressive B-cell Non-Hodgkin Lymphoma

Who this might be right for
Non Hodgkin Lymphoma
University of Cologne 3
Early research (Phase 1)WithdrawnNCT02657447
What this trial is testing

Dosimetry Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma (LYMRIT-37-02)

Who this might be right for
Non-Hodgkin Lymphoma
Nordic Nanovector
Testing effectiveness (Phase 2)Ended earlyNCT01045382
What this trial is testing

MSC and HSC Coinfusion in Mismatched Minitransplants

Who this might be right for
Leukemia, Myeloid, AcuteLeukemia, Lymphoblastic, AcuteLeukemia, Myelocytic, Chronic+6 more
University of Liege 39
Testing effectiveness (Phase 2)UnknownNCT05596097
What this trial is testing

Zanubrutinib in Maintenance Therapy of DLBCL Patients With Initial Remission

Who this might be right for
Diffuse Large B-cell Lymphoma (DLBCL)
LanZhou University 15
Early research (Phase 1)Ended earlyNCT03320642
What this trial is testing

GRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host Disease

Who this might be right for
Hematologic Malignancies
Incyte Corporation 84
Testing effectiveness (Phase 2)Ended earlyNCT06088654
What this trial is testing

Phase1/2 Study of IPH6501 in Patients With Relapsed /Refractory B-Cell Non-Hodgkin Lymphoma

Who this might be right for
Non Hodgkin Lymphoma
Innate Pharma 23
Early research (Phase 1)UnknownNCT05349266
What this trial is testing

Assessment of Safety and Efficacy of ThisCART19A in Adult Patients With B-NHL After Failure of Autologous Chimeric Antigen Receptor T- Cell(CAR-T) Therapy

Who this might be right for
Non-Hodgkin's Lymphoma
Zhejiang University 16
Early research (Phase 1)Study completedNCT00058227
What this trial is testing

Alvocidib, Fludarabine Phosphate, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell Lymphoma

Who this might be right for
B-cell Chronic Lymphocytic LeukemiaContiguous Stage II Grade 1 Follicular LymphomaContiguous Stage II Grade 2 Follicular Lymphoma+40 more
National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT05192486
What this trial is testing

GNC-038, a Tetra-specific Antibody, in Participants With R/R Diffuse Large B-cell Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B-cell Lymphoma
Sichuan Baili Pharmaceutical Co., Ltd. 12
Testing effectiveness (Phase 2)Study completedNCT00634179
What this trial is testing

A Phase I/II Trial of VR-CHOP in Lymphoma Patients

Who this might be right for
Lymphoma, B-CellFollicular Lymphoma
Emory University 37
Not applicableStudy completedNCT03985696
What this trial is testing

Exosomes and Immunotherapy in Non-Hodgkin B-cell Lymphomas

Who this might be right for
Lymphoma, B-cell, Aggressive Non-Hodgkin (B-NHL)
University Hospital, Limoges 90
Testing effectiveness (Phase 2)Looking for participantsNCT07508605
What this trial is testing

Efficacy and Safety of CD19/CD20 CAR/TRuC-T in Relapsed/Refractory B-Cell Lymphoma

Who this might be right for
Relapsed/Refractory B-cell Lymphoma
Shenzhen University General Hospital 20
Not applicableStudy completedNCT07103486
What this trial is testing

Evaluate the Therapeutic Benefit of Tisagenlecleucel Compared to Existing Standard of Care in German Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma
Novartis Pharmaceuticals 264
Testing effectiveness (Phase 2)Looking for participantsNCT07371923
What this trial is testing

Application of Zanubrutinib-based Combination Regimens in the Treatment of Newly-diagnosed Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma (DLBCL)
Beijing Tongren Hospital 50
Testing effectiveness (Phase 2)Study completedNCT02207062
What this trial is testing

Ibrutinib in Treating Patients With Relapsed or Refractory Transformed Indolent B-cell Non-Hodgkin Lymphoma

Who this might be right for
Recurrent Transformed B-Cell Non-Hodgkin LymphomaRefractory Transformed B-Cell Non-Hodgkin Lymphoma
University of Washington 20
Next Page